Why the study?
Do diuretics like indapamide and low-dose chlorthalidone provide mortality benefit with fewer side effects in primary hypertension?
Do diuretics like indapamide and low-dose chlorthalidone provide mortality benefit with fewer side effects in primary hypertension?
Indapamide and low-dose chlorthalidone remain effective choices for primary hypertension, offering mortality benefits with fewer side effects than high-dose diuretics.
Answers are grounded in this paper and cite their sources.
May support indapamide preference in hypertension; leaves open need for prospective RCTs.
Diuretics have long been cherished as drugs of choice for uncomplicated primary hypertension. Robust mortality and morbidity data is available for diuretics to back this strategy. Off-late the interest for diuretics has waned off perhaps due to availability of more effective drugs but more likely due to perceived lack of tolerance and side-effect profile of high-dose of diuretics required for mortality benefit. Low-dose diuretics particularly thiazide diuretics are safer but lack the mortality benefit shown by high-dose. However, indapamide and low dose chlorthalidone have fewer side-effects but continue to provide mortality benefit.
No takes yet. Share an insight, caveat, or question.
Sundeep Mishra (2016) conducted an editorial in Primary hypertension. Diuretics (thiazide and thiazide-like) was evaluated.
Synapse has enriched 10 related papers. Consider them for comparative context: